Anticancer Research: 32 (2)

Index by author

February 2012; Volume 32,Issue 2

Experimental Studies

You have access
Role of the Apoptotic and Mitotic Regulator Survivin in Melanoma
JODI A. MCKENZIE and DOUGLAS GROSSMAN

Anticancer Research February 2012, 32 (2) 397-404;
You have access
Tumor Interstitial Fluid as Modulator of Cancer Inflammation, Thrombosis, Immunity and Angiogenesis
GIANFRANCO BARONZIO, LAURENT SCHWARTZ, MIKHAIL KISELEVSKY, ADELINE GUAIS, EDWARD SANDERS, GLORIA MILANESI, MIRIAM BARONZIO and ISABEL FREITAS

Anticancer Research February 2012, 32 (2) 405-414;
You have access
Quantitative MRI Establishes the Efficacy of PI3K Inhibitor (GDC-0941) Multi-Treatments in PTEN-deficient Mice Lymphoma
STEPHAN WULLSCHLEGER, JUAN M. GARCÍA-MARTÍNEZ and SUZANNE L. DUCE

Anticancer Research February 2012, 32 (2) 415-420;
You have access
Polymorphisms of the Epidermal Growth Factor Receptor (EGFR) and Survival in Patients with Advanced Cancer of the Head and Neck (HNSCC)
JAN STOEHLMACHER-WILLIAMS, LUISE OBERMANN, GERHARD EHNINGER and ERAY GOEKKURT

Anticancer Research February 2012, 32 (2) 421-425;
You have access
Oncogenic MST1R Activity in Pancreatic and Gastric Cancer Represents a Valid Target of HSP90 Inhibitors
CHRISTIAN MOSER, SVEN A. LANG, CHRISTINA HACKL, HONG ZHANG, KAREN LUNDGREN, VICTOR HONG, ANDRES MCKENZIE, BERNHARD WEBER, JUNG S. PARK, HANS J. SCHLITT, EDWARD K. GEISSLER, YOUNG D. JUNG and OLIVER STOELTZING

Anticancer Research February 2012, 32 (2) 427-437;
You have access
Elevated Expression of IRS2 in the Progression from Neurofibroma to Malignant Peripheral Nerve Sheath Tumor
CHRISTIANA M. SHAW, STEPHEN R. GROBMYER, DENIZ A. UCAR, WILLIAM G. CANCE, JOHN D. REITH and STEVEN N. HOCHWALD

Anticancer Research February 2012, 32 (2) 439-443;
You have access
Effect of PI3K/Akt Pathway Inhibition-Mediated G₁ Arrest on Chemosensitization in Ovarian Cancer Cells
MIRELA FEKETE, CHINTDA SANTISKULVONG, CAROL ENG and OLIVER DORIGO

Anticancer Research February 2012, 32 (2) 445-452;
You have access
Preclinical Activity of the Novel Orally Bioavailable HSP90 Inhibitor NVP-HSP990 against Multiple Myeloma Cells
THORSTEN STÜHMER, KAMOL ISKANDAROV, ZHENHAI GAO, THOMAS BUMM, EVELYN GRELLA, MICHAEL R. JENSEN, HERMANN EINSELE, MANIK CHATTERJEE and RALF C. BARGOU

Anticancer Research February 2012, 32 (2) 453-462;
You have access
The Dual Kinase Inhibitor NVP-BEZ235 in Combination with Cytotoxic Drugs Exerts Anti-proliferative Activity towards Acute Lymphoblastic Leukemia Cells
CATRIN SCHULT, MEIKE DAHLHAUS, AENNE GLASS, KRISTIN FISCHER, SANDRA LANGE, MATHIAS FREUND and CHRISTIAN JUNGHANSS

Anticancer Research February 2012, 32 (2) 463-474;
You have access
Evaluation of Breast Cancer Susceptibility Loci on 2q35, 3p24, 17q23 and FGFR2 Genes in Taiwanese Women with Breast Cancer
CHIEN-YU LIN, CHENG-MAO HO, DA-TIAN BAU, SHU-FEN YANG, SHU-HUI LIU, PO-HAN LIN, TSAI-HSIU LIN, NI TIEN, MU-CHIN SHIH and JANG-JIH LU

Anticancer Research February 2012, 32 (2) 475-482;
You have access
Caveolin-1 Attenuates Hydrogen Peroxide-induced Oxidative Damage to Lung Carcinoma Cells
WONGSAKORN SUCHAOIN and PITHI CHANVORACHOTE

Anticancer Research February 2012, 32 (2) 483-490;
You have access
C-reactive Protein is a Potential Prognostic Factor for Metastatic Gastric Cancer
TAKAYA SHIMURA, MIKA KITAGAWA, TOMONORI YAMADA, MASAHIDE EBI, TSUTOMU MIZOSHITA, SATOSHI TANIDA, HIROMI KATAOKA, TAKESHI KAMIYA and TAKASHI JOH

Anticancer Research February 2012, 32 (2) 491-496;
You have access
Involvement of MAP Kinases in the Cytotoxicity of Acyclic Nucleoside Phosphonates
HELENA MERTLÍKOVÁ-KAISEROVÁ, MICHAELA NEJEDLÁ, ANTONÍN HOLÝ and IVAN VOTRUBA

Anticancer Research February 2012, 32 (2) 497-501;
You have access
Expression Profiles of Signal Transduction Genes in Ex Vivo Drug-resistant Pediatric Acute Lymphoblastic Leukemia
JOANNA SZCZEPANEK, MONIKA POGORZALA, MICHAL JARZAB, MALGORZATA OCZKO-WOJCIECHOWSKA, MALGORZATA KOWALSKA, ANDRZEJ TRETYN, MARIUSZ WYSOCKI, BARBARA JARZAB and JAN STYCZYNSKI

Anticancer Research February 2012, 32 (2) 503-506;
You have access
Putative Supramolecular Complexes Formed by Carotenoids and Xanthophylls with Ascorbic Acid to Reverse Multidrug Resistance in Cancer Cells
JÓZSEF MOLNÁR, JULIANNA SERLY, ROZÁLIA PUSZTAI, IRÉN VINCZE, PÉTER MOLNÁR, GYÖRGYI HORVÁTH, JÓZSEF DELI, TAKASHI MAOKA, ATTILA ZALATNAI, HARUKUNI TOKUDA and HOYOKU NISHINO

Anticancer Research February 2012, 32 (2) 507-517;
You have access
Cytotoxicity of Hydrophylic Silver Carboxylato Complexes
ELEANOR FOURIE, ELIZABETH ERASMUS, JANNIE C. SWARTS, ANDRÉ TUCHSCHERER, ALEXANDER JAKOB, HEINRICH LANG, GISELA K. JOONE and CONSTANCE E.J. VAN RENSBURG

Anticancer Research February 2012, 32 (2) 519-522;
You have access
P53 Mutation and LOH at Chromosome 9 in Urothelial Carcinoma
TAMAS BEOTHE, ANETTA NAGY, LASZLO FARKAS and GYULA KOVACS

Anticancer Research February 2012, 32 (2) 523-527;

Clinical Studies

You have access
Oral Metronomic Cyclophosphamide with and without Methotrexate as Palliative Treatment for Patients with Metastatic Breast Carcinoma
VITTORIO GEBBIA, HAMOUDA BOUSSEN and MARIA ROSARIA VALERIO

Anticancer Research February 2012, 32 (2) 529-536;
You have access
The Evaluation of E-Cadherin and Vimentin as Biomarkers of Clinical Outcomes Among Patients with Non-small Cell Lung Cancer Treated with Erlotinib as Second- or Third-line Therapy
FRANK RICHARDSON, G DAVID YOUNG, REGINA SENNELLO, JULIE WOLF, GRETCHEN M. ARGAST, PETER MERCADO, ANGELA DAVIES, DAVID M. EPSTEIN and BRET WACKER

Anticancer Research February 2012, 32 (2) 537-552;
You have access
The Effect of Radiotherapy on Implant-based Breast Reconstruction in the Setting of Skin-sparing Mastectomy: Clinical Series and Review of Complications
KENNETH HUGHES, CHARLES BROWN, VICTOR PEREZ, JEANNETTE W.C. TING, WARREN M. ROZEN, IAIN S. WHITAKER and RICHARD KORENTAGER

Anticancer Research February 2012, 32 (2) 553-557;
You have access
The Expression of MAGE and SSX, and Correlation of COX2, VEGF, and Survivin in Colorectal Cancer
JONGSOON CHOI and HEEKYUNG CHANG

Anticancer Research February 2012, 32 (2) 559-564;
You have access
Determination of Chronic Inflammatory States in Cancer Patients Using Assay of Reactive Oxygen Species Production by Neutrophils
YOKO SUZUKI, SATOSHI OHNO, RYUJI OKUYAMA, ATSUSHI ARUGA, MASAKAZU YAMAMOTO, SHIGEKI MIURA, HIROSHI YOSHIOKA, YUICHI MORI and KATSUHIKO SUZUKI

Anticancer Research February 2012, 32 (2) 565-570;
You have access
Human Papilloma Virus, Herpes Simplex Virus and Epstein Barr Virus in Oral Squamous Cell Carcinoma from Eight Different Countries
JAMSHID JALOULI, MIRANDA M. JALOULI, DIPAK SAPKOTA, SALAH O. IBRAHIM, PER-ANDERS LARSSON and LARS SAND

Anticancer Research February 2012, 32 (2) 571-580;
You have access
Pelvic Dysfunctions and Quality of Life after Nerve-sparing Radical Hysterectomy: A Multicenter Comparative Study
MARCELLO CECCARONI, GIOVANNI ROVIGLIONE, EMANUELA SPAGNOLO, PAOLO CASADIO, ROBERTO CLARIZIA, MICHELE PEIRETTI, FRANCESCO BRUNI, INGE PETERS and GIOVANNI ALETTI

Anticancer Research February 2012, 32 (2) 581-588;
You have access
Prognostic Value of Biomarkers Related to Drug Resistance in Patients with Advanced Epithelial Ovarian Cancer
HAERYOUNG KIM, KIDONG KIM, JAE HONG NO, YONG-TARK JEON, HYE WON JEON and YONG-BEOM KIM

Anticancer Research February 2012, 32 (2) 589-594;
You have access
Treatment Evaluation of Metastatic Lymph Nodes after Concurrent Chemoradiotherapy in Patients with Head and Neck Squamous Cell Carcinoma
GOSHI NISHIMURA, HIDEKI MATSUDA, TAKAHIDE TAGUCHI, MASAHIRO TAKAHASHI, MASANORI KOMATSU, DAISUKE SANO, NAOKO SAKUMA, YASUHIRO ARAI and HIDEAKI TAKAHASHI

Anticancer Research February 2012, 32 (2) 595-600;
You have access
Impacts of Treatment Lines and Initiation Timing of Erlotinib for Advanced Non-small Cell Lung Cancer
TAKUYA AOKI, SATOSHI IGAWA, NAOKI FURUYA, MASATO KATAGIRI, JUNICHIROU HISATA, SAKURAKO TAJIRI, NAOKI HAYAMA, MASAMICHI MINESHITA, TETSUYA URANO, TERUOMI MIYAZAWA, NORIYUKI MASUDA and TADASHI ABE

Anticancer Research February 2012, 32 (2) 601-608;
You have access
A Retrospective Study of Chemotherapy with and without Pemetrexed in Malignant Pleural Mesothelioma
MASAYOSHI HIGASHIGUCHI, HIDEKAZU SUZUKI, TOMONORI HIRASHIMA, MASASHI KOBAYASHI, SHO GOYA, NORIO OKAMOTO, YUKA MATSUURA, MOTOHIRO TAMIYA, NAOKO MORISHITA, TEPPEI TSUMORI and ICHIRO KAWASE

Anticancer Research February 2012, 32 (2) 609-613;
You have access
Intermediate Oncological Outcomes of Percutaneous Radiofrequency Ablation for Small Renal Tumors: Initial Experience
YUJIRO NITTA, TOMOAKI TANAKA, KAZUYA MORIMOTO, TETSUYA MAKINO, NORIAKI NISHIKAWA, KOUICHIRO TASHIRO, TOSHIHIDE NAGANUMA, TARO IGUCHI, TOSHIYUKI MATSUOKA and TATSUYA NAKATANI

Anticancer Research February 2012, 32 (2) 615-618;
You have access
Inflammation-based Prognostic Score for Hepatocellular Carcinoma Patients on Sorafenib Treatment
MANABU MORIMOTO, KAZUSHI NUMATA, SATOSHI MORIYA, MASAAKI KONDO, AKITO NOZAKI, YU MORIOKA, SHIN MAEDA and KATSUAKI TANAKA

Anticancer Research February 2012, 32 (2) 619-623;
You have access
Detection of Human Papillomavirus Genotypes in Bronchial Cancer Using Sensitive Multimetrix Assay
K. SYRJÄNEN, M. SILVONIEMI, E. SALMINEN, T. VASANKARI and S. SYRJÄNEN

Anticancer Research February 2012, 32 (2) 625-631;
You have access
Docetaxel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC): an Observational Study in a Single Institution
D. SCHALLIER, L. DECOSTER, J. BRAECKMAN, C. FONTAINE and J. DEGRÈVE

Anticancer Research February 2012, 32 (2) 633-641;
You have access
A Randomized Comparison of Modified Intermediate-dose Ara-C versus High-dose Ara-C in Post-remission Therapy for Acute Myeloid Leukemia
TOSHIHIRO FUKUSHIMA, YOSHIMASA URASAKI, MASAKI YAMAGUCHI, MIKIO UEDA, KOJI MORINAGA, TOSHIHIRO HABA, TOSHIRO SUGIYAMA, SHINJI NAKAO, HIDEKI ORIGASA, HISANORI UMEHARA and TAKANORI UEDA

Anticancer Research February 2012, 32 (2) 643-647;
You have access
Improved Radiotherapy for Primary and Secondary Liver Cancer: Stereotactic Body Radiation Therapy
CHAD TAO and LI-XI YANG

Anticancer Research February 2012, 32 (2) 649-655;
You have access
Assessment of Sexual Function in Patients with Cancer Undergoing Radiotherapy – A Single Centre Prospective Study
DIMITRIOS VOMVAS, GREGORIS ICONOMOU, EVANTHIA SOUBASI, MICHAIL LEOTSINIDIS, HARALABOS P. KALOFONOS, STAVROULA BERATIS, DIMITRIOS KARDAMAKIS and KONSTANTINOS ASSIMAKOPOULOS

Anticancer Research February 2012, 32 (2) 657-664;
You have access
Significance of Surgical Treatment of Liver Metastases from Gastric Cancer
YUICHIRO MIKI, KAZUMASA FUJITANI, MOTOHIRO HIRAO, YUKINORI KUROKAWA, MASAYUKI MANO, MASANORI TSUJIE, ATSUSHI MIYAMOTO, SHOJI NAKAMORI and TOSHIMASA TSUJINAKA

Anticancer Research February 2012, 32 (2) 665-670;
You have access
The mRNA Expression of DAP3 in Human Breast Cancer: Correlation with Clinicopathological Parameters
U. WAZIR, W. G. JIANG, A.K. SHARMA and K. MOKBEL

Anticancer Research February 2012, 32 (2) 671-674;
You have access
Comparison of Vinorelbine plus Cisplatin and S-1 plus Cisplatin in Concurrent Chemoradiotherapeutic Regimens for Unresectable Stage III Non-small Cell Lung Cancer
TAKEHITO SHUKUYA, TOSHIAKI TAKAHASHI, HIDEYUKI HARADA, HIROAKI AKAMATSU, CHIKARA SAKAGUCHI, HISAO IMAI, AKIRA ONO, YUKIKO NAKAMURA, ASUKA TSUYA, HIROTSUGU KENMOTSU, TATEAKI NAITO, HARUYASU MURAKAMI, MASAHIRO ENDO, KAZUHISA TAKAHASHI and NOBUYUKI YAMAMOTO

Anticancer Research February 2012, 32 (2) 675-680;
You have access
Comparison of Concurrent Chemoradiotherapy versus Induction Chemotherapy Followed by Radiation in Patients with Nasopharyngeal Carcinoma
MASANORI KOMATSU, MAMORU TSUKUDA, HIDEKI MATSUDA, CHOICHI HORIUCHI, TAKAHIDE TAGUCH, MASAHIRO TAKAHASHI, GOHSHI NISHIMURA, MAKIKO MORI, TATUO NIHO, JUNICHI ISHITOYA, YASUNORI SAKUMA, MARIKO HIRAMA and OSAMU SHIONO

Anticancer Research February 2012, 32 (2) 681-686;
You have access
Reported Intake of Selected Micronutrients and Risk of Colorectal Cancer: Results from a Large Population-based Case–control Study in Newfoundland, Labrador and Ontario, Canada
ZHUOYU SUN, YUN ZHU, PEIZHONG PETER WANG, BARBARA ROEBOTHAN, JING ZHAO, JINHUI ZHAO, ELIZABETH DICKS, MICHELLE COTTERCHIO, SHARON BUEHLER, PETER T. CAMPBELL, JOHN R. MCLAUGHLIN and PATRICK S. PARFREY

Anticancer Research February 2012, 32 (2) 687-696;
You have access
Metastatic Renal Cell Carcinoma Treated Sequentially with Multiple VEGF Receptor-targeted Inhibitors – A Case Report
CLAUDE LINASSIER, DELPHINE CARMIER, PIERRE COMBE, BENJAMIN FAIVRE D'ARCIER, FRANCK BRUYERE and BERANGERE NARCISO

Anticancer Research February 2012, 32 (2) 697-700;
You have access
Complete Pathological Response after Sequential Therapy with Sunitinib and Radiotherapy for Metastatic Clear Cell Renal Carcinoma
GEOFFROY VENTON, AURELIE DUCOURNAU, EMMANUEL GROSS, ERIC LECHEVALLIER, ALEXANDRE ROCHWERGER, GEORGES CURVALE, JEAN-VINCENT ZINK, SEBASTIEN SALAS and JEAN-LAURENT DEVILLE

Anticancer Research February 2012, 32 (2) 701-705;
You have access
Mini-laparotomy versus Vaginal Surgery for Class II-III Obese Patients with Early-stage Endometrial Cancer
MASSIMILIANO FAMBRINI, ANNALISA PIERALLI, UBALDO BITOSSI, KARIN L. ANDERSSON, GIANFRANCO SCARSELLI, LORENZO LIVI, GIANLUIGI TADDEI and MAURO MARCHIONNI

Anticancer Research February 2012, 32 (2) 707-712;
You have access
Errata
Anticancer Research February 2012, 32 (2) 713;
You have access
Errata
Anticancer Research February 2012, 32 (2) 713;

BOOK REVIEWS

You have access
Book Reviews
Anticancer Research February 2012, 32 (2) 715;
You have access
Laser Capture Microdissection. Methods and Protocols. Second Edition
Anticancer Research February 2012, 32 (2) 715;
You have access
Diagnostic Pathology of Ovarian Tumors
Anticancer Research February 2012, 32 (2) 715;
You have access
Epigenetics Protocols. Second Edition
Anticancer Research February 2012, 32 (2) 715;
You have access
Molecular Chaperones. Methods and Protocols
Anticancer Research February 2012, 32 (2) 715-716;
You have access
Kinase Inhibitors. Methods and Protocols
Anticancer Research February 2012, 32 (2) 716;
You have access
FNA Cytology of Ophthalmic Tumors
Anticancer Research February 2012, 32 (2) 716;
You have access
Current Concepts in Ureal Melanoma
Anticancer Research February 2012, 32 (2) 716;
You have access
Nanomedicine – Basic and Clinical Applications in Diagnostics and Therapy
Anticancer Research February 2012, 32 (2) 716-717;
You have access
Mouse as a Model Organism. From Animals to Cells
Anticancer Research February 2012, 32 (2) 717;
You have access
Cushing's Syndrome. Pathophysiology, Diagnosis and Treatment
Anticancer Research February 2012, 32 (2) 717;
You have access
Handbook of ELISPOT. Methods and Protocols
Anticancer Research February 2012, 32 (2) 717;
You have access
Oxford American Handbook of Hospice and Palliative Medicine
Anticancer Research February 2012, 32 (2) 717-718;
You have access
Prostate Cancer
Anticancer Research February 2012, 32 (2) 718;
You have access
After Prostate Cancer
Anticancer Research February 2012, 32 (2) 718;
You have access
Oxford American Mini-Handbook of Genitourinary Cancers
Anticancer Research February 2012, 32 (2) 718;
You have access
Oxford American Mini-Handbook of Gastrointestinal Cancers
Anticancer Research February 2012, 32 (2) 718;
You have access
Oxford American Mini-Handbook of Hematologic Malignancies
Anticancer Research February 2012, 32 (2) 718-719;
You have access
Targeted Therapies in Breast Cancer
Anticancer Research February 2012, 32 (2) 719;
You have access
Targeted Therapy in Non-Small Lung Cancer
Anticancer Research February 2012, 32 (2) 719;
You have access
Opioid Prescribing Toolkit
Anticancer Research February 2012, 32 (2) 719;
You have access
Colloids and Interface in Life Sciences and Bionanotechnology. Second Edition
Anticancer Research February 2012, 32 (2) 719;
You have access
The History of Oncology
Anticancer Research February 2012, 32 (2) 719-720;
You have access
Medical Tests Sourcebook. Fourth Edition
Anticancer Research February 2012, 32 (2) 720;
You have access
Handbook for Mortals. Second Edition
Anticancer Research February 2012, 32 (2) 720;

Main menu

User menu

Search

Index by author

Experimental Studies

Clinical Studies

BOOK REVIEWS

In this issue

Jump to